Skip to main content
. 2018 Sep 17;3:15. doi: 10.1038/s41536-018-0041-8

Fig. 1.

Fig. 1

SMD and 95% CI for the VAS pain score between pre and post MSC treatment at final follow-up (n = 318). The diamond represents the pooled SMD using the DerSimonian-Laird method. The vertical line at 0 represents no difference. MSC treatment was effective in improving VAS pain score (pooled SMD: −1.45, 95% CI: −1.94, −0.96; P < 0.001). SMDs were highly heterogeneous among studies (I2: 84%; P < 0.001)